Equity-Accounted Investees and Joint Business - Net of deposits (Details) € in Millions, $ in Millions |
1 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Jul. 31, 2021 |
Jul. 31, 2021 |
Dec. 31, 2025
USD ($)
|
Feb. 03, 2025
USD ($)
|
Feb. 03, 2025
EUR (€)
|
Jan. 02, 2025
USD ($)
|
Jan. 02, 2025
EUR (€)
|
Dec. 31, 2024
EUR (€)
|
|
| Group 3 centers and Group 4 centers | ||||||||
| Equity-Accounted Investees and Joint Business | ||||||||
| Total business combination cost | $ 140 | $ 281 | € 268 | € 134 | ||||
| Group 3 centers | ||||||||
| Equity-Accounted Investees and Joint Business | ||||||||
| Total business combination cost | $ 79 | € 75 | ||||||
| Group 4 centers | ||||||||
| Equity-Accounted Investees and Joint Business | ||||||||
| Total business combination cost | $ 62 | € 59 | ||||||
| Biotek America LLC | ||||||||
| Equity-Accounted Investees and Joint Business | ||||||||
| Proportion of ownership interest in joint arrangement | 75.00% | 75.00% | ||||||
| Percentage of economic exposure to assets and liabilities | 100.00% | 100.00% | ||||||